 | ||
|
Mycoplasmas - Stealth Pathogens
Mycoplasmas however, do not have a cell wall, and like a tiny jellyfish with a pliable membrane, can take on many different shapes which make them difficult to identify, even under a high powered electron microscope. Mycoplasmas can also be very hard to culture in the laboratory and are often missed as pathogenic causes of diseases for this reason.
The accepted name was chosen because Mycoplasmas were observed to have a fungi-like structure (Mycology is the study of fungi - hence "Myco") and it also had a flowing plasma-like structure without a cell wall - hence "plasma". The first strains were isolated from cattle with arthritis and pleuro-pneumonia in 1898 at the Pasteur Institute.
The first human strain was isolated in 1932 from an abscessed wound.
The first connection between mycoplasmas and rheumatoid diseases was made in 1939 by Drs. Swift and Brown. Unfortunately, mycoplasmas didn't become part of the medical school curriculum until the late 1950's when one specific strain was identified and proven to be the cause of atypical pneumonia, and named Mycoplasma pneumonia.
The association between immunodeficiency and autoimmune disorders with mycoplasmas was first reported in the mid 1970s in patients with primary hypogammaglobulinemia (an autoimmune disease) and infection with four species of mycoplasma that had localized in joint tissue. Since that time, scientific testing methodologies have made critical technological progress and along with it, more mycoplasma species have been identified and recorded in animals, humans and even plants.
While Mycoplasma pneumonia is certainly not the only species causing disease in humans, it makes for a good example of how this stealth pathogen can move out of it's typical environment and into other parts of the body and begin causing other diseases. While residing in the respiratory tract and lungs, Mycoplasma pneumonia remains an important cause of pneumonia and other airway disorders, such as tracheobronchitis, pharyngitis and asthma.
When this stealth pathogen hitches a ride to other parts of the body, it is associated with non-pulmonary manifestations, such as blood, skin, joint, central nervous system, liver, pancreas, and cardiovascular syndromes and disorders. Even as far back as 1983, doctors at Yale noted:
"Over the past 20 years the annual number of reports on extrapulmonary symptoms during Mycoplasma (M.) pneumoniae disease has increased. Clinical and epidemiological data indicate that symptoms from the skin and mucous membranes, from the central nervous system, from the heart, and perhaps from other organs as well are not quite uncommon manifestations of M. pneumoniae disease."(15)
This single stealth pathogen has been discovered in the urogenital tract of patients suffering from inflammatory pelvic disease, urethritis, and other urinary tract diseases. (8)
It has been discovered in the heart tissues and fluid of patients suffering from cardititis, pericarditis, tachycardia, hemolytic anemia, and other coronary heart diseases.(9, 10, 14) It has been found in the cerebrospinal fluid of patients with meningitis and encephalitis, seizures, ALS, Alzheimer's and other central nervous system infections, diseases and disorders.(11-13)
It has even been found regularly in the bone marrow of children with leukemia.(16- 18) It is amazing that one single tiny bacteria can be the cause of so many seemingly unrelated diseases in humans. But as with all mycoplasma species, the disease is directly related to where the mycoplasma resides in the body and which cells in the body it attaches to or invades.
Today, over 100 documented species of mycoplasmas have been recorded to cause various diseases in humans, animals, and plants.
Mycoplasma pneumonia as well as at least 7 other mycoplasma species have now been linked as a direct cause or significant co-factor to many chronic diseases including, rheumatoid arthritis, Alzheimer's, multiple sclerosis, fibromyalgia, chronic fatigue, diabetes, Crohn's Disease, ALS, nongonoccal urethritis, asthma, lupus, infertility, AIDS and certain cancers and leukemia, just to name a few.(1-6)
In 1997, the National Center for Infectious Diseases, Centers for Disease Control and Prevention's journal, Emerging Infectious Diseases, published the article, Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety, by Drs. Baseman and Tully who stated:
"Nonetheless, mycoplasmas by themselves can cause acute and chronic diseases at multiple sites with wide-ranging complications and have been implicated as cofactors in disease. Recently, mycoplasmas have been linked as a cofactor to AIDS pathogenesis and to malignant transformation, chromosomal aberrations, the Gulf War Syndrome, and other unexplained and complex illnesses, including chronic fatigue syndrome, Crohn's disease, and various arthritides."
Mycoplasmas, unlike viruses, can grow in tissue fluids (blood, joint, heart, chest and spinal fluids) and can grow inside any living tissue cell without killing the cells, as most normal bacteria and viruses will do.
Mycoplasmas are frequently found in the oral and genito-urinary tracts of normal healthy people and are found to infect females four times more often than males, which just happens to be the same incidence rate in rheumatoid arthritis, fibromyalgia, Chronic Fatigue and other related disorders.(7) Mycoplasmas are parasitic in nature and can attach to specific cells without killing the cells and thus their infection process and progress can go undetected.
In some people the attachment of mycoplasmas to the host cell acts like a living thorn; a persistent foreign substance, causing the host's immune defense mechanism to wage war. This allergic type of inflammation often results in heated, swollen, and painful inflamed tissues, like those found in rheumatoid diseases, fibromyalgia and many other autoimmune disorders like lupus and MS, Crohn's and others.
In such cases the immune system begins attacking itself and/or seemingly healthy cells. Some species of mycoplasmas also have the unique ability to completely evade the immune system. Once they attach to a host cell in the body, their unique plasma and protein coating can then mimic the cell wall of the host cell and the immune system cannot differentiate the mycoplasma from the body's own host cell.
Mycoplasmas are parasitic in nature because they rely on the nutrients found in host cells including cholesterol, amino acids, fatty acids and even DNA.
They especially thrive in cholesterol rich and arginine-rich environments. Mycoplasmas can generally be found in the mucous membrane in the respiratory tract. They need cholesterol for membrane function and growth, and there is an abundance of cholesterol in the bronchial tubes of the respiratory tract. Once attached to a host cell, they then begin competing for nutrients inside the host cells.
As nutrients are depleted, then these host cells can begin to malfunction, or even change normal functioning of the cell, causing a chain reaction with other cells (especially within the immune and endocrine systems). Mycoplasmas can even cause RNA and DNA mutation of the host cells and have been linked to certain cancers for this reason.
Mycoplasmas can also invade and live inside host cells which evade the immune system, especially white blood cells. Once inside a white blood cell, mycoplasmas can travel throughout the body and even cross the blood/brain barrier, and into the central cervous system and spinal fluid.
Footnotes
Baseman, Joel, et.al., Mycoplasmas:
Sophisticated, Reemerging, and Burdened by Their Notoriety, CDC, Journal
of Infectious Diseases, Vol 3, No.1, Feb 1997
S-C. Mycoplasmas and
AIDS. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors.
Mycoplasmas: molecular biology and pathogenesis. Washington (DC): American
Society for Microbiology, 1992:525-45.
Nicolson G, Nicolson NL. Diagnosis and
treatment of mycoplasmal infections in Gulf War illness-CFIDS patients.
Intl J Occup Med Immunol Toxicol 1996;5:69-78.
Wear DJ, et.al. Mycoplasmas and
oncogenesis:persistent infection and multistage malignant transformation.
Proc Natl Acad Sci USA 1995;92:10197-201.
Ekbom A, Daszak P, Kraaz W, Wakefield AJ.
Crohn's disease after in-utero measles virus exposure. Lancet
1996;348:516-7.
Taylor-Robinson D. Mycoplasmas in rheumatoid
arthritis and other human arthritides. J Clin Pathol 1996;49:781-2.
Dr.Harold Clark, The Intercessor, June 1993,
The Road Back Foundation, Delaware OH.
Goulet M, et.al., Isolation of Mycoplasma
pneumoniae from the human urogenital tract. J Clin Microbiol
1995;33:2823-5
Daxbock F, et.al., Severe hemolytic anemia
and excessive leukocytosis masking mycoplasma pneumonia. Ann Hematol. 2001
Mar;80(3):180-2.
Higuchi ML, et.al., Detection of Mycoplasma
pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques.
Braz J Med Biol Res. 2000 Sep;33(9):1023-6.
Socan M, Neurological symptoms in patients
whose cerebrospinal fluid is culture- and/or polymerase chain
reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis. 2001 Jan
15;32(2):E31-5.
Bencina D, et.al., Intrathecal synthesis of
specific antibodies in patients with invasion of the central nervous
system by Mycoplasma pneumoniae. Eur J Clin Microbiol Infect Dis. 2000
Jul;19(7):521-30
Smith R, et.al., Neurologic manifestations of
Mycoplasma pneumoniae infections: diverse spectrum of diseases. A report
of six cases and review of the literature. Clin Pediatr (Phila). 2000
Apr;39(4):195-201.
Umemoto M, Advanced atrioventricular block
associated with atrial tachycardia caused by Mycoplasma pneumoniae
infection. Acta Paediatr Jpn. 1995 Aug;37(4):518-20.
Lind K. Manifestations and complications of
Mycoplasma pneumoniae disease: a review.Yale J Biol Med. 1983
Sep-Dec;56(5-6):461-8.
Alexander FE. Is Mycoplasma Pneumonia
associated with childhood acute lymphoblastic leukemia? Cancer Causes
Control. 1997 Sep;8(5):803-11.
Hall JE, Mycoplasma pneumonia in acute
childhood leukemia. Pediatr Pulmonol. 1985 Nov-Dec;1(6):333-6.
Murphy WH, Gullis C, Dabich L, Heyn R, Zarafonetis CJD. Isolation of Mycoplasma from leukemic and nonleukemia patients. J Nat Cancer Inst 1970;45:243-51.
How Mycoplasmas Interact In The Body
To understand how mycoplasmas can cause widespread disease, we must first look at the species' unique properties and interactions with host cells. Unlike viruses and bacteria, mycoplasmas are the smallest free-living and self-duplicating microorganisms, as they don't require living cells to replicate their DNA and growth.
Mycoplasmas are able to hide inside the cells of the host (patient) or to attach to the outside of host cells.
Whether they live inside or outside the host cell, they depend on host cells for nutrients such as cholesterol, amino acids, etc. They compete with the host cells for these nutrients which can interfere with host cell function without killing the host cell.
A mycoplasma has very little DNA of its own, but is capable of using DNA from a host cell. When a mycoplasma takes over the DNA of the host cell, anything can happen - including causing that cell to malfunction in many different ways and/or die, or can cause DNA mutation of the host cell.
Mycoplasmas attach to host cells with a tiny arm coated in protein which attaches to the protein coating of host cells. For this reason, antibiotics like tetracycline, which are classified as "protein synthesis inhibitors" are often used against mycoplasma infections. While these antibiotics may block this protein attachment and very slowly starve it from the nutrients it needs from host cells to thrive and replicate, it still takes a healthy immune system to actually kill the mycoplasma for good.
Mycoplasmas are highly adaptable to changing environments and can move anywhere in the body, attaching to or invading virtually any type of cell in the body.
The mycoplasma adhesion proteins are very similar to human proteins. Once adhered to the host cell, the mycoplasma can completely mimic or copy the protein cell of the host cell. This can cause the immune system to begin attacking the body's own cells; an event that happens in all autoimmune diseases.
Certain Mycoplasma species can either activate or suppress host immune systems, and they may use these activities to evade host immune responses. Mycoplasmas can turn on the chain reaction called an immune system response. This includes the stimulation of pro-inflammatory cytokines (chemical messengers of the immune system) which is generally found in most autoimmune and inflammatory diseases and disorders.
Mycoplasma can also attach to or invade immune system cells, like the very phagocytes (natural killer cells) that are supposed to kill them. Inside these phagocytes, they can be carried to new locations of inflammation or disease - hidden away like a spy who has infiltrated the defending army.
When a mycoplasma attaches to a host cell, it generates and releases hydrogen peroxide and superoxide radicals which cause oxidative stress and damage to the surrounding tissues.
The
Main Human Mycoplasma Pathogens
Pathogen / Implicated Disease
(1-6)
| Mycoplasma genitalium | Arthritis, chronic nongonococcal urethritis, chronic pelvic inflammatory disease, other urogenital infections and diseases, infertility, AIDS/HIV |
| Mycoplasma fermentans | Arthritis, Gulf War Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Lupus, AIDS/HIV, autoimmune diseases, ALS, psoriasis and Scleroderma, Crohn's and IBS, cancer, endocrine disorders, Multiple Sclerosis, diabetes |
| Mycoplasma salivarium | Arthritis, TMJ disorders, Eye and ear disorders and infections, gingivitis, periodontal diseases including even cavities. |
| Mycoplasma hominis and Ureaplasma urealyticum | Two mycoplasmas commonly found in the urogenital tracts of healthy persons. However, over the years, the pathogenic roles of these mycoplasmas have been proven in adult urogenital tract diseases, neonatal respiratory infections, and a range of other diseases usually in immunocompromised patients. |
| Mycoplasma pneumonia | Pneumonia, asthma, upper and lower respiratory diseases, heart diseases, leukemia, CNS disorders and diseases, urinary tract infections, Crohn's and Irritable Bowel Syndrome, autoimmune diseases. |
| Mycoplasma incognitus
and Mycoplasma penetrans |
AIDS/HIV, urogenital infections and diseases, Autoimmune disorders and diseases |
| Mycoplasma pirum | Urogenital infections and diseases, AIDS/HIV |
DR. MERCOLA'S COMMENT:
One can use the protocol I modified to treat rheumatoid arthritis.
It has also become quite obvious and clear that NST is one of the most useful therapies as it helps to rebalance the autonomic nervous system and secondarily the immune system so it can defeat stealth pathogens like mycoplasma.
Footnotes
Krause DC, Taylor-Robinson D. Mycoplasmas
which infect humans. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB,
editors. Mycoplasmas: molecular biology and pathogenesis. Washington (DC):
American Society for Microbiology, 1992:417-44.
Murray HW, Masur H, Senterfit LB, Roberts RB.
The protean manifestations of Mycoplasma pneumoniae infection in adults.
Am J Med 1975;58:229-42.
Baseman, Joel, et.al., Mycoplasmas:
Sophisticated, Reemerging, and Burdened by Their Notoriety. CDC, Journal
of Infectious Diseases, Vol 3, No.1, Feb 1997
Blanchard, A., et.al., AIDS-associated
mycoplasmas. Ann.Rev.Microbiol. 1994; 48:687-712.
Hawkins, et.al., Association of mycoplasma
and human immunodeficiency virus infection: detection of amplified
mycoplasma fermentans DNA in blood. J.Infec.Dis. 1992: 165:581-585
Hussain AI, et.al., Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children. J Clin Microbiol. 1999 May;37(5):1518-23.
rain-tree.com
If you
find this newsletter interesting and valuable, help support it by
recommending it to some friends by using this button.